ClinicalTrials.gg
RecruitingNCT05385302SOCIO-SASUpdated Feb 6, 2024

Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients

An observational study in Adherence, Treatment, Health Literacy and Obstructive Sleep Apnea, sponsored by University Hospital, Grenoble. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-06.

Sponsored by University Hospital, Grenoble · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Sep 2022; still recruiting 4 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
250
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Treatment Adherence and Compliance with a site in France — 9 open to participants now, 11 under way, none of them phase 3. Treatment Adherence and Compliance · France.

Planned enrollment
5th of 11
250 · median 153
Started
2022
with 2 others
Observational
11 of 25
3 open now
Primary completion
2024-12
later than 2 of 10 live
Registered
17th of 25
by date
Lead sponsor
2 of 25
University Hospital, Grenoble

Among the 25 studies in Treatment Adherence and Compliance with a site in France, this one is the 5th largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2022, is one of 11 observational ones, reaches primary completion later than 2 of the 10 other live ones, and was the 17th registered.

Treatment Adherence and Compliance

353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.

Browse Treatment Adherence and Compliance studies →

Open to participants now

9 of the 25 studies in Treatment Adherence and Compliance with a site in France are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Treatment Adherence and Compliance with a site in France, or all of them as a file.
02

Study summary

Multicentric, prospective, opened study to evaluate the impact of Health Literacy Levels on CPAP withdrawal in Obstructive Sleep Apnea patients within 6 months of inclusion.

Read the detailed description

Obstructive sleep apnea syndrome (OSA) is a chronic multi-organ pathology and heterogeneous in its presentation and phenotypes.

To date, continuous positive airway pressure (CPAP) is the first-line treatment for OSA. In France, 1.2 million patients are treated with CPAP but 15% of patients refused the device at the time of diagnosis and the rate of non-adherence reach 43% 3 years after CPAP initiation.

Both in terms of sleepiness and cardiovascular symptoms, clinical improvement is correlated with normalization of ventilation and therefore with the use of CPAP throughout the sleep period by the patients. Adherence to CPAP is nowadays achieved by the contribution of tele-observance, which provides prescribers, home health care providers and patients with daily feedback on the effectiveness and compliance of the therapy.

To date, studies targeting the predictive factors of CPAP compliance in OSA patients mainly include clinical data (age, sex, severity of OSAS, symptoms, etc.), or technical factors directly related to CPAP treatment (type of mask, residual apnea hypopnea index (AHI) under treatment, leakage, side effects, etc.).

The social, socioeconomic and psychological approaches are far less studied and frankly underestimated, although they are gradually gaining interest, representing the submerged part of the iceberg. Some studies have shown an association between poor socioeconomic status and poor compliance with CPAP, while others have focused on psychological factors. Finally, in the work of our team, we have recently looked at the impact of the marital on compliance and the perception of the associated benefit. However, each study targets a specific area, without taking into account the clinical and individual determinants. Therefore, there is a lack of knowledge about individual determinants of CPAP adherence.

Health literacy, defined as "the ability to access, understand, evaluate, and communicate information in ways that promote, maintain, and improve one's health in a variety of settings across the lifespan" is a possible important limitation for a patient to understand the need for PAP treatment and was never explored in view to explain CPAP adherence.

This project aims to exploit a unique transdisciplinary approach to characterize refusal, discontinuation, and nonadherence to CPAP in patients with diagnosed OSA newly managed on CPAP.

The main hypothesis of the study is that a patient with an insufficient level of health literacy (LS) (score from 0 to 8 defined from the European Health Literacy Survey questionnaire) has a greater probability of stopping treatment early or of being non-compliant than a patient with better performance in terms of health literacy.

03

Conditions studied

  • Adherence, Treatment
  • Health Literacy
  • Obstructive Sleep Apnea

Keywords

  • Adherence
  • treatment refusal
  • CPAP
  • Obstructive sleep apnea
  • Health literacy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Obstructive Sleep Apnea patients with cPAP indication

Eligibility criteria

Inclusion Criteria:

  • Patient newly diagnosed with OSA
  • Patient with indication for CPAP
  • Voluntary patient with and no objection to participation
  • Patient affiliated with or benefiting from a social security plan

Non-Inclusion Criteria:

  • Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure (patient under guardianship or curators) according to articles L1121-5 to L1121-8
  • Refusal of participation by the patient
  • Patient refusing telemonitoring
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
250 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. To study the impact of health literacy levels on CPAP discontinuation in newly fitted OSA patients

    Proportion of CPAP treatment discontinuation without switch to mandibular advancement orthosis treatment

    Time frame: Between initiation of CPAP (day 7 to 15 after inclusion) to V2 (6 months after inclusion)

Secondary outcomes

  1. To study the impact of health literacy levels on CPAP refusal after diagnosis.

    Proportion of CPAP refusals after diagnosis

    Time frame: At V1 (inclusion)

  2. To investigate the impact of health literacy levels on adherence status. With adherence status defined here in several ways (≥4h vs <4h; adherence quartiles or adherence clusters).

    Average CPAP adherence

    Time frame: At 6 month (V2)

  3. To study the interactions between the different socio-economic factors studied and their influence on adherence to the CPAP treatment

    Average CPAP adherence

    Time frame: At 6 month

  4. Define the relationship between various clinical, social, economic, environmental determinants and adherence in addition to health literacy.

    Average CPAP adherence

    Time frame: At 6 months

  5. Identify profiles of patients who refuse CPAP or are non- adherent or who have stopped CPAP according to personal determinants

    Adherent, non-adherent, or discontinued status. With adherence status defined here in several ways (≥ 4 hours per night for at least 70% of the nights ; adherence quartiles or adherence clusters).

    Time frame: At 6 months

  6. Determine adherence trajectories as a function of health literacy and specifically study the specific determinants of adherence.

    Daily CPAP adherence data obtained by telemonitoring

    Time frame: Over 6 months

  7. To decipher the links made by people in treatment discontinuation or qualified as non-observant from the medical point of view, between the different factors of non-observance identified.

    Criteria identified on the basis of analyses of the corpus carried out from semi-structured interviews concerning knowledge of the pathology, the relationship with the treatment, the relationship with health professionals, and the life trajectory in terms of health care, making it possible to better understand patients' non-adherence.

    Time frame: within 15 days of refusal of CPAP treatment, or within 15 days of discontinuation of treatment during the 6-month follow-up, or within 15 days of visit 2 for both non-adherent and adherent patients at 6 months.

  8. Understand how people explain these situations based on their life contexts, representations of the disease and treatment, particularly their understanding of the issues involved.

    Criteria identified on the basis of analyses of the corpus carried out from semi-structured interviews concerning knowledge of the pathology, the relationship with the treatment, the relationship with health professionals, and the life trajectory in terms of health care, making it possible to better understand patients' non-adherence.

    Time frame: Within 15 days of refusal of treatment for patients refusing CPAP, or within 15 days of discontinuation of treatment for patients who stopped treatment during the 6-month follow-up, or within 15 days of visit 2 for non-adherent patients at 6 month

  9. Analyze people's perceptions of their health information practices, their relationship with the medical profession and the role of those involved in their pathology to understanding CPAP treatment

    Criteria identified on the basis of analyses of the corpus carried out from semi-structured interviews concerning knowledge of the pathology, the relationship with the treatment, the relationship with health professionals, and the life trajectory in terms of health care, making it possible to better understand patients' non-adherence.

    Time frame: Within 15 days of refusal of treatment for patients refusing CPAP, or within 15 days of discontinuation of treatment during the 6-month follow-up, or within 15 days of visit 2 for all patients at 6 month

  10. Identify the change in adherent patient's relationship to their treatment and the perceived benefits

    Criteria identified on the basis of analyses of the corpus carried out from semi-structured interviews concerning knowledge of the pathology, the relationship with the treatment, the relationship with health professionals, and the life trajectory in terms of health care, making it possible to better understand patients' adherence.

    Time frame: Within 6 months of the first interview

  11. Describe the evolution of non-adherent patient's situation, the health and potential compensation strategies or alternatives that they have implemented to limit the impact of their untreated OSAS

    Criteria identified on the basis of analyses of the corpus carried out from semi-structured interviews concerning knowledge of the pathology, the relationship with the treatment, the relationship with health professionals, and the life trajectory in terms of health care, making it possible to better understand patients' non-adherence.

    Time frame: Within 6 months of the first interview for non-adherent patients

07

Study locations

2 of 2 sites recruiting
  • CHUGA
    La Tronche, 38043, France
    Recruiting
    • BAILLY · Contactsbailly@chu-grenoble.fr · +3347676698
    • JL PEPIN · Sub investigator
    • R TAMISIER · Sub investigator
    • M DESTORS · Sub investigator
    • S BAILLIEUL · Sub investigator
    • R CLIN · Sub investigator
    • S BAILLY · Principal investigator
  • Centre du Sommeil de Grenoble
    Saint-Martin-d'Hères, France
    Recruiting
08

References and documents

Publications

  • Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pepin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9. PubMed 31300334 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2022 (actual). Primary completion is estimated for Dec 2024, 27 months after the start.

Of 35 observational studies under Treatment Adherence and Compliance, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 48. This study's planned 27 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
May 17, 2022
First posted
May 23, 2022
StartActual
Sep 22, 2022
Primary completionEst.
Dec 2024
CompletionEst.
Jul 2025
Last update
Feb 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05385302
Collaborators
ODENORE, HP2 Laboratory
Responsible party
Sponsor
First posted
May 23, 2022
Start date
Sep 22, 2022
Primary completion
Dec 2024 (estimated)
Completion
Jul 2025 (estimated)
Last update
Feb 6, 2024

Study contacts

Sébastien Bailly, PharmD, PhD
Contact
sbailly@chu-grenoble.fr
+33 476 766 918
Andry Rakotovao, PhD
Contact
arakotovao@chu-grenoble.fr
+33 476 769 265
Sébastien Bailly, PharmD, PhD
principal investigator · Sleep and respiratory diseases Lab, CHU Grenoble Alpes

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion